PrP与α-synuclein相遇:分子机制和对疾病的影响
Tuane C R G Vieira1, Caroline A Barros1, Renato Domingues2
1Institute of Medical Biochemistry Leopoldo de Meis and National Institute of Science and Technology for Structural Biology and Bioimaging, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Journal of neurochemistry
|October 19, 2023
概括
蛋白 (PrP) 与α-synuclein (aSyn) 的相互作用对于像帕金森病这样的synucleinopathies至关重要. 细胞PrP (PrPC) 可能充当受体,调解aSyn传播并提供潜在的治疗点.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 蛋白质化学 蛋白质化学
背景情况:
- 蛋白 (PrP) 的发现彻底改变了对蛋白质错折疾病的理解.
- 阿尔法-同核素 (aSyn) 错误折叠和聚合驱动帕金森病和同核素病变.
- aSyn病理的细胞间传播是一个关键的疾病机制.
研究的目的:
- 提供aSyn和细胞PrP (PrPC) 之间的相互作用的全面概述.
- 讨论这种相互作用在同核蛋白病变中的作用.
- 识别知识缺口和潜在的治疗途径.
主要方法:
- 对PrP和aSyn结构,功能和聚合的现有文献的审查.
- 对研究PrPC作为蛋白质聚合物的受体的研究分析.
- 对aSyn-PrPC相互作用的当前理解的综合.
主要成果:
- PrPC可以作为aSyn聚合物的受体或传感器.
- 这种相互作用与aSyn病理的细胞间传播有关.
- 在各种神经退行性疾病中观察到PrPC的作用.
结论:
- aSyn和PrPC之间的相互作用是同核蛋白病变进展的关键因素.
- 了解这种相互作用可能会揭示帕金森病和相关疾病的新疗法策略.
- 需要进一步的研究,以充分阐明机制和治疗潜力.
相关概念视频
Amyloid Fibrils
9.6K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.6K
Neural Regulation
39.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.5K
Parkinson's Disease: Overview
567
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
567


